MedTrace Logo

Real-World Study of Young Patients With Solid Tumors in China

NCT07708935 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 12000

Last updated 2026-07-16

No results posted yet for this study

Summary

To evaluate organ preservation rates, fertility preservation, and long-term quality of life after treatment among young patients.

Conditions

Interventions

OTHER

Ages 18-40

Young Cohort (Core Population): Patients aged ≤40 years at the time of initial diagnosis of a malignant tumor. Older Control Cohort: Patients aged \>40 years at the time of initial diagnosis of a malignant tumor, selected proportionally according to the incidence of each tumor type and propensity score matching principles.

Sponsors & Collaborators

  • Fudan University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-31
Primary Completion
2027-07-31
Completion
2027-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07708935 on ClinicalTrials.gov